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INTRODUCTION
Otitis media with effusion (OME) is one of the most common ear
diseases in children and it is a major cause of hearing loss (1, 2).
Etiologically, OME has been associated with upper respiratory infec-
tion, Eustachian tube dysfunction, allergic rhinitis and immuno-
logical and environmental factors (3), and bacterial infection caused
by Eustachian tube dysfunction is considered one of the most im-
portant causes (4). In addition to the bacterial infection itself, vari-
ous inflammatory mediators released after infection and persistent
immunological reactions have been considered as major causes
of OME (5).
The innate immune system is involved first during host reac-
tions to pathogens. Subsequently, antigen presenting cells (APC)
have been shown to secrete various cytokines, chemokines and
costimulatory signals, leading to the activation of the adaptive
immune system (3). Among the factors involved in the activation
of the innate immune system are pattern recognition receptors,
pathogen-associated molecule patterns (PAMPs) and Toll-like recep-
tors (TLRs). TLRs are membrane proteins that have been detect-
ed in the defense system of mammalians and Drosophila. To date,
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Objectives. Toll-like receptors (TLRs) detect microbial infections and they can directly induce innate host defense respons-
es. TLR 2 has been shown to be primarily involved in the recognition of peptidoglycans and lipoteichoic acid of gram
positive bacteria. TLR 4 recognizes lipopolysaccharides and lipoteichoic acids from both gram-negative and gram-
positive bacteria. Both mutations lead a reduced capacity to elicit inflammation and they increase the risk for
gram-positive and negative infections. This study was performed to investigate the expressions of TLR 2 and 4 and
their mutations in patients suffering with otitis media and middle ear effusion.
Methods. Middle ear fluid samples were collected from 40 otitis media effusion (OME) patients who had ventilating tubes
inserted. Bacteria in the effusion fluid were detected by standard bacterial culture. The secreted IgG, IgA and IgM
were measured by Enzyme-linked immunosorbent assay. TLR 2 and 4 were assessed by performing RT-PCR. The
genomic DNA from each patient was isolated from the middle ear fluid samples that were collected from 60 OME
patients, and the presence of mutations was determined by performing restriction digestion and DNA sequencing
analysis.
Results. Among the 40 middle ear fluid samples, bacteria were detected in 13 middle ear fluid samples. The amounts of
IgM, IgA, and IgG were 151.20± ±60.94 ng/mL, 21.59± ±7.96 ng/mL and 11.55± ±16.98 ng/mL, respectively. TLR 2 and
4 were expressed in the middle ear fluid and the expression of TLR 2 was higher than that of TLR 4. However, there
was no correlation between the expressions of TLR 2 and 4, and the concentration of immunoglobulin or the pres-
ence of bacteria (P>0.05). There ware no mutations of TLR 2 (Arg753Gln, Arg677Trp) and TLR 4 (Asp299Gly,
Thr399Ile).
Conclusion. TLR 2 and 4 were expressed in all the middle ear fluid samples of OME, but the mutations of TLR 2 and 4 were
not detected. TLR 2 and 4 may play a vital role in the immunological responses of patients with OME.
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Original Article11 TLR subtypes have been identified in humans and they have
been shown to be involved in the recognition of PAMPs in the
innate immune system (6, 7). Upon the recognition of ligands by
TLRs, NF-κ B is activated through the MyD88-dependent and
MyD88-independent pathways, and this induces the expression
of inflammatory genes that encode cytokines and cell conjuga-
tion molecules (8, 9). Among the TLR subtypes, TLR 2 and TLR
4 have been reported to recognize pathogenic bacteria. TLR 2
has been found to be the receptor for the cell wall components of
gram positive bacteria, such as peptidoglycans, lipoteichoic acid
and lipoproteins, and TLR 4 has been observed to bind to the
toxic pneumolysin ligand produced by gram positive bacteria,
as well as binding to the major component of gram negative bac-
teria lipopolysaccharide (LPS) (10-12).
Two single nucleotide polymorphisms (SNPs) of TLR 2, Arg
677Trp and Arg753Gln, and two SNPs of TLR 4, Asp299Gly and
Thr399Ile have recently been shown to be associated with the
susceptibility to pathogenic bacteria because the TLRs with these
polymorphisms have a decreased ability to bind to ligands (13,
14). So, we have assessed the role of these TLRs in the develop-
ment of OME by assaying the expression of wild type and mutant
TLR 2 and TLR 4, and the secretion of immunoglobulin in the
fluid of the middle ear.
MATERIALS AND METHODS
The study was performed on 100 pediatric patients who under-
went insertion of ventilation tubes for treating chronic OME in
the Department of Otorhinolaryngology at our hospital between
March 2005 and August 2006. The B and C types of OME were
diagnosed by impedance audiometry, as well as by the presence
of an air-fluid level and air bubbles behind the tympanic mem-
brane and an amber colored tympanic membrane by otoscopic
examination. Prior to surgery, the external auditory canal was
cleaned with potadine solution, and the exudate was sterilely col-
lected in an effendorf tube with using a collector (Jhun typ. Tap),
and this was stored at -70℃. The use of the samples and the pur-
pose of experiment were explained to the parents and guardians,
and written informed consent was obtained. The children suspect-
ed of having head and neck anomalies, systemic disease or con-
genital or acquired immunodeficiency were excluded from the
study. The 100 pediatric patients were divided into 40 and 60
OME patients. In 40 samples, the bacteria in the effusion fluid
were detected by standard bacterial culture, and the secreted IgG,
IgA and IgM were measured by enzyme-linked immunosorbent
assay, and the TLR 2 and 4 were assessed by RT-PCR. They were
23 boys and 17 girls in this group. Their mean age was 4.5 yr. In
the 60 samples, the genomic DNA from each patient was isolat-
ed and the presence of mutations was determined by restriction
digestion and DNA sequencing analysis. They were 27 boys and
33 girls in this group. Their mean age was 4.9 yr. 
Bacterial culture
The exudates were mixed with Stuart’s transport medium, trans-
ported to a microbiology laboratory, inoculated onto blood agar
medium and thioglycollate liquid medium, and then they were
cultured at 35℃for 24 hr. The bacterial colonies were identified
by gram staining and biochemical tests.
Enzyme-linked immunosorbent assay (ELISA)
All the samples of middle ear effusion were stored at -80℃, and
their IgG, IgA, and IgM concentrations were measured by ELISA.
Briefly, 50 μ L of 1:100 goat anti-human IgG, anti-human IgA
and anti-human IgM in coating buffer (1.59 g Na2CO3+2.93 g
NaHCO3+5% NaN3, pH 9.6) were placed in each well of a 96
well plate and this was allowed to incubate overnight at 4℃. The
wells were washed 6 times, blocking antibody was added and
50 μ L of each sample was added to each well, and the plates were
incubated at room temperature for 3 hr. The wells were washed
6 times, and purified goat anti-human IgG, anti-human IgA, and
anti-human IgM conjugated to horseradish peroxidase in PBS/
Tween/BSA solution was added; the plates were then incubated
at room temperature. The plates were washed 6 times, substrate
solution (2,2′ -AZINO-Bis) was added and the optical absorbance
was measured at 450 nm (Bethyl, Montgomery, TX, USA).
RNA extraction
The cultured cells were lysed by adding 1 mL RNA-Bee solution
(Tel-test, Inc, Friendswood, TX, USA) to a 60 mm culture dish.
Each sample of cells was mixed with 0.2 times volume of chlo-
roform, they were kept on ice for 5 min and next centrifuged at
12,000×g for 15 min at 4℃(Centrifuge5402, Eppendorf, Germany).
An equal volume of isopropanol was added to each supernatant,
and these were allowed to precipitate at room temperature for
10 min. Following centrifugation at 12,000 g for 5 min at 4℃,
the supernatant was discarded, and each pellet was washed with
800 μ L of 75% ethanol, centrifuged at 7,500×g for 5 min at 4℃
and then air dried for 10 min. Each pellet was resuspended in
DEPC-water, and the RNA concentration of each sample was
measured at 260 nM with using a spectrophotometer (Ultraspec
2000, Pharmacia Biotech, Cambridge, England). The absorbance
ratio at A260/A280 of each sample was 1.5-1.8, and the RNA sam-
ples were stored at -70℃.
Reverse transcription-polymerase chain reaction
To synthesize the complementary deoxynucleotide acid (cDNA),
1 μ g RNA was adjusted to 10 μ L with DEPC-treated water; this
was then heated at 70℃for 5 min and kept on ice for 5 min. To
each sample was added 2 μ L 10×reaction buffer (100 mM Tris-
HCl, pH9.0, 500 mM KCl, 1% Triton X-100), 4 μ L 25 mM MgCl2,
2 μ L 10 mM deoxynucleoside triphosphates (dNTPs), 0.5 μ L (40
units/μ L) ribonuclease (RNase) inhibitor and 15 units AMV reverse
transcriptase (Promega, Madison, WI, USA), after which the vol-
ume was adjusted to 20 μ L and the samples were incubated at
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The TLR 2 and TLR 4 primers are shown in Table 1. Each PCR
reaction consisted of 2 μ L cDNA, 5 μ L 10× PCR buffer (100 mM
Tris-HCl, pH 8.3, 500 mM KCl, 15 mM MgCl2), 4 μ L 2.5 mM
dNTPs, 20 pmol of sense and antisense primer and 2 units Taq
DNA polymerase (Takara, Shiga, Japan), and this was adjusted
to 50 μ L with sterile distilled water. The amplification protocol
consisted of an initial denaturation at 95℃ for 5 min, followed
by 30 cycles (25 for β -actin) of denaturation at 95℃ for 1 min,
annealing at 55℃for 1 min and extension at 72℃for 1 min, fol-
lowed by a final extension at 72℃ for 10 min (Biometra, Got-
tingen, Germany). A 10 μ L aliquot of each PCR product was
mixed with 2 μ L of 6× loading buffer (0.25% bromophenol blue,
0.25% xylene cyanol, 30% sucrose) and this was electrophoresed
on a 2% agarose gel containing 0.5 μ g/mL ethidium bromide
with using 0.5× TBE buffer (45 mM Tris-borate, 1 mM EDTA)
at 90 volts for 1 hr. The bands were assessed using the Gel Doc
1000 gel documentation system (Bio-Rad, Hercules, CA, USA).
Real-time PCR
To a 1.5 mL test tube was added 2.4 μ L 25 mM MgCl2, DNA
master SYBR green I containing 2 μ L Lightcycler fast start enzyme
and 10 pmol of the sense and antisense primers, respectively,
with the final volume adjusted to 18 μ L with distilled water. To
each tube was added 2 μ L cDNA, and the samples were aliquot-
ed into capillary tubes and centrifuged at 700×g for 5 sec and
then they were placed in a Lightcycler amplifier (Roche Applied
Science, Mannheim, Germany). The annealing temperature for
TLR 2, TLR 4 and β -actin was 55℃, and real-time PCR was per-
formed at 25 bp/sec, depending on the size of the PCR products.
The crossing point of TLR 2 or TLR 4 with β -actin was applied to
the formula, 2
-(TLR2/4-βactin) and the relative amounts of TLR 2 or
TLR 4 were quantitated.
Genotyping of the TLR-2 and TLR-4 genes 
The TLR-2 and TLR-4 genes were amplified using the primers
shown in Table 2 (15). To 100 ng genomic DNA was added 1
×PCR buffer (10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM
MgCl2), 0.2 mM of each dNTP, 10 pmol of each primer and 1 unit
of AmpliTaq Gold DNA polymerase (Roche, Applied Biosystems,
Foster City, CA, USA), with the final volume adjusted to 25 μ L
with distilled water. Following initial denaturation at 94℃for 14
min, the samples were subjected to 35 cycles of denaturation at
94℃for 30 sec, the proper annealing temperature for 30 sec (64℃
for Arg677Trp and Arg753Gln, 65℃ for Asp299Gly and 62℃
for Thr399Ile), and extension at 72℃for 30 sec, with a final ex-
tension step at 72℃for 10 min.
Restriction enzyme digestion of the PCR products 
To 15 μ L of each PCR product was added 1×enzyme reaction
buffer and 10 units of each restriction enzyme (Table 3; New En-
gland Biolabs, Beverly, MA, USA), with the volume adjusted to
20 μ L with distilled water, and this was reacted at 37℃ (Nco I,
Hinf I, and Msp I) or 60℃(Mwo I) for 16 hr. Each reaction prod-
uct was mixed with 4 μ L 6X gel loading dye (30% sucrose, 0.05%
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Gene Sequence Product size (bp)
Table 1. Primers for real-time RT-PCR
TLR 2 5′ -GCCAAAGTCTTGATTGATTGG-3′ 347
5′ -TTGAAGTTCTCCAGCTCCTG-3′
TLR 4 5′ -TGGATACGTTTCCTTATAAG-3′ 507
5′ -GAAATGGAGGCACCCCTTC-3′
β -actin 5′ -CTTCTACAATGAGCTGCGTG-3′ 305
5′ -TCATGAGGTAGTCAGTCAGG-3′
RT-PCR: reverse transcriptase-polymerase chain reaction; TLR: toll-like
receptors.
TLR: toll-like receptors.
PCR: polymerase chain reaction; TLR: toll-like receptors.
GenePolymorphism Primers
Table 2. PCR primer sequences
TLR 2 Arg677Trp F:5′ -CCCCTTCAAGTTGTGGCTTCATAAG-3′
R:5′ -AGTCCAGTTCATACTTGCACCAC-3′
Arg753Gln F:5′ -CATTCCCCAGCGCTTCTGCAAGCTCC-3′
R:5′ -GGAACCTAGGACTTTATCGCAGCTC-3′
TLR 4 Asp299Gly F:5′ -AGCATACTTAGACTACTACCTCCATG-3′
R:5′ -GAGAGATTTGAGTTTCAATGTGGG-3′
Thr399Ile F:5′ -GGTTGCTGTTCTCAAAGTGATTTTGGGAGAA-3′
R:5′ -GGAAATCCAGATGTTCTAGTTGTTCTAAGCC-3′
Gene Polymorphism Restriction enzyme Restriction temp (℃) Length of the restriction fragments
Table 3. Restriction enzymes and the length of the restriction fragments
TLR 2 Arg677Trp MwoI 60℃ Wild type (allele C): 130 bp+22 bp
Arg677Trp (allele G): 152 bp 
TLR 2 Arg753Gln MspI 37℃ Wild type (allele G): 104 bp+25 bp
Arg753Gln (allele G): 129 bp
Wild type (allele A): 188 bp
TLR 4 Asp299Gly NcoI 37℃ Asp299Gly (allele G): 168 bp+20 bp
TLR 4 Thr399Ile HinfI 37℃ Wild type (allele C): 124 bp
Thr399Ile (allele T): 98 bp+26 bpbromophenol, 0.05% xylene cyanol) and this was electrophoresed
on a 2.5% agarose gel containing 0.5 μ g/mL ethidium bromide in
0.5×electrophoresis buffer (45 mM Tris-borate, 1 mM EDTA)
at 90 volts for 1 hr. The polymorphisms were assessed by a gel
imaging analysis (Gel Doc 1000 Gel Documentation System, Bio-
Rad, Hercules, CA, USA). 
The differences in the immunoglobulin and TLR expressions
between the patients from whom bacteria were not isolated and
were isolated were compared by the Mann-Whitney test. Corre-
lations between IgA, IgG, IgM, and TLR 2 and TLR 4 were ana-
lyzed by the Spearman correlation test. All the calculations
were performed using SPSS 11.5 for Windows. P values less than
0.05 considered statistically significant. 
RESULTS
We attempted to culture bacteria from the exudates taken from
the 40 patients. Of these 40 samples, 13 were positive for bac-
teria and 27 were negative. The detected bacteria were S. pneu-
moniae, H. influenzae, M. catarrhalis, MRSA, coagulase negative
Staphylococcus, S. pyogenes, Bacillus and Gram-negative rods. 
The concentrations of IgA, IgG, and IgM in the exudates from
the 13 patients who were positive for bacteria (21.59±7.96 ng/
mL, 11.55±16.98 ng/mL, and 151.20±60.94 ng/mL, respectively)
were higher than the concentrations in the exudates from the
27 patients who were negative for bacteria (20.98±5.99 ng/mL,
10.96±4.27 ng/mL, and 145.32±48.70 ng/mL, respectively), but
the differences were not statistically significant (P>0.05), (Fig. 1).
TLR 2 and TLR 4 mRNA were detected in the middle ear
exudates, with the level of TLR 2 mRNA being higher than the
level of TLR 4 mRNA. However, the levels of TLR 2 and TLR 4
mRNA were similar in the 13 patients who were positive for bac-
teria and the 27 patients who were negative for bacteria (P>0.05)
(Fig. 2, 3).
We did not detect the TLR 4 gene mutations, TLR 4 (Asp299Gly)
and TLR 4 (Thr399Ile), or the TLR 2 gene mutations, TLR 2
(Arg 753Gln) and TLR 2 (Arg677Trp), in any of these samples
(Fig. 4).
The IgA, IgG, and IgM levels in the exudates did not correlate
with the TLR 2 and TLR 4 mRNA (P>0.05), (Table 4).
DISCUSSION
In patients with OME, exudates are retained in the middle ear
cavity. Most children have at least one episode of OME before
the age of 4 yr, and it is the most common cause of hearing loss
in children (2). Eustachian tube dysfunction and inflammatory
reactions induced by viruses and bacteria are important causes
of OME, and the exudates produced within the middle ear cavi-
ty are thought to be due to inflammatory reactions. Thus, analy-
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Fig. 1. Concentrations of IgA, IgG, and IgM in the effusion fluid of OME according to the culture results.
Fig. 2. Comparison of the TLR 2, TLR 4, and TLR 9 ex-
pressions according to the culture results.
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tions in middle ear infections.
The human immune system is composed of the innate and ac-
quired immune systems, which act together against pathogens.
The innate immune system recognizes microbial non-self, as well
as molecules that are present only in microorganisms. The recep-
tors of the innate immune system that recognize the molecular
patterns pertinent to pathogens are called pattern-recognition
receptors. These receptors sense invading pathogens and they
recognize pathogen-related molecular patterns and signals that
induce the expression of cytokines, chemokines and other signal-
ing molecules, and they activate biological defense mechanisms
such as reactive nitrogen, reactive oxygen and anti-peptide mol-
ecules (16). In addition, upon the recognition of a pathogen-asso-
ciated molecular pattern, CD80 and CD86 are induced on anti-
gen presenting cells, indicating that the adaptive immune system
is derived from the innate immune system (17).
Among the receptors that recognize patterns in the innate im-
mune system are the TLRs, of which 11 types have been currently
identified in humans. The TLRs have been reported to be expressed
primarily on primary defense cells, including dendritic cells, ma-
crophages, neutrophils, T cells and B cells (18). Each TLR consists
of an intracellular domain, a transmembrane domain and an extra-
cellular domain. Upon the recognition of the pathogen-associat-
ed molecular pattern of a microorganism by the extracellular
domain of a TLR, NF-κ B is activated through the MyD88-depen-
dent and -independent pathways. NF-κ B subsequently migrates
to the nucleus where it acts as a transcription factor, and it induces
the activation of cytokines or co-stimulatory signals, thus bridg-
ing the innate immune system and the acquired immune system
(8, 9).
TLR 2 has been reported to be stimulated primarily by lipopro-
teins and peptidoglycans of gram positive bacteria, as well as it
reacts with the lipoprotein that’s present on the surface of Myco-
bacterium tuberculosis, Borrelia burgdorferi, Treponema pallid-
ium, Mycoplasma fermentans, fungus cell walls and mycobacte-
rial lipoarabinomannan (10).
TLR 4 has been reported to recognize the major component
of gram negative bacteria cell wall LPS, and it induces innate
immune reactions. Moreover, TLR 4 has been found to react with
the toxic factor pneumolysin that’s produced by gram positive
bacteria, thereby inducing inflammatory reactions (11, 19). 
TLRs recognize invasive viruses, bacteria and fungi at early
stages, and by inducing the expression of innate immune medi-
ators such as the complement cascade, the TLRs play a role as
sentinels for the activation of local inflammation. TLR 2 and TLR 3
are expressed on airway epithelium and, following stimulation
by their ligands, they help produce β -defensins (20). Moreover,
in the sinus mucosa, TLR 4 is expressed less than TLR 1, TLR 2,
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TLR2 TLR4
Table 4. Correlation between TLR 2 and TLR 4, and IgG, IgA, and
IgM expressions
IgG r=0.117 (P=0.562) r=0.207 (P=0.301)
IgA r=-0.184 (P=0.358) r=-0.171 (P=0.394)
IgM r=-0.226 (P=0.256) r=-0.324 (P=0.099)
r: spearman correlation coefficient.
Fig. 3. The expression of TLR2, TLR4, and TLR9 mRNA in the mid-
dle ear fluid from patients with otitis media with effusion. The mRNA
expression was measured by RT-PCR and it was resolved on 2%
agarose gel by electrophoresis.
Lane 1: 100 bp DNA ladder; lane 2: normal PBL; lane 3-7: patients.
TLR 2, TLR 4, and TLR 9 and β -actin mRNA were expressed in all
the patients.
347 bp TLR2
M1234567
TLR4
β -actin
507 bp
305 bp
Fig. 4. Polymorphism of the TLR2 (Arg677Trp and Arg753Gln) and
TLR4 (Asp299Gly and Thr399Ile) genes in the middle ear fluid from
patients with OME. The genomic DNA was amplified by PCR, and the
products were digested with MwoI (TLR2 Arg677Trp), MsPI (TLR2
Arg753Gln), NcoI (TLR4 Asp299Gly), and HinfI (TLR4 Thr399Ile) restric-
tion enzymes, and then they were separated on 3% agarose gel by
electrophoresis.
Lane 1: normal PBL; lane 2-5: patients; lane 6: 100 bp DNA ladder; lane
7: normal PBL; lane 8-11: patients. TLR2 (Arg677Trp and Arg753Gln)
and TLR4 (Asp299Gly and Thr399Ile) were absent from all the patients.
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TLR2Arg753Gln
TLR4Asp299Gly
TLR4Thr399Ile
12345 M 67891 0
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100 bpTLR 3 and TLR 5 (21). In addition, defensins were found to be
more abundantly expressed in palatine tonsils and adenoid tis-
sues than in the non-mucosal cells in response to TLR stimula-
tion (22). Further, the TLR 2 expression was increased in
epithelial cells of an otitis media model that was caused by
Hemophilus influenzae (23). We have shown here that TLR 2 and
TLR 4 mRNA were expressed in the middle ear fluids of patients
with OME, with TLR 2 expression being higher than that of TLR
4. These findings confirm that the presence of TLR is involved
in the development of OME. However, when we compared the
TLR 2 and TLR 4 mRNA expressions in patients for whom we
did and did not identify bacteria, we found that the differences
were not statistically significant. For about 3 months prior to
surgery, these patients had been treated with antibiotics, which
may have had an effect on the expression of these TLRs. 
TLRs on B cells recognize pathogen-associated molecular pat-
terns, they help activate B cells and they induce the production
of low affinity IgM (24). LPS and CpG-DNA activate the signal
transduction pathways of B cells and also TLR 4 and TLR 9, and
so they play an important role in the proliferation of B cells and
immunoglobulin synthesis, whereas bacterial lipoproteins activate
TLR 2 and they stimulate B cells (25). Moreover, TLR signal trans-
duction is important for the production of IgM, IgG1, and IgG2c,
but it does not influence the production of IgA (26). When we
measured the concentrations of IgG, IgA, and IgM in the exudates,
we found that the level of IgM was the highest among the 3 types
of antibodies. However, there were no differences in expressions
of IgG, IgA, and IgM in the exudates that did and did not contain
bacteria, suggesting there no association between the antibody
concentration in the middle ear and the presence or absence of
bacteria. Furthermore, we did not observe a significant associa-
tion between the expressions of IgG, IgA, and IgM, which are asso-
ciated with the adaptive immune system, and the expressions of
TLR 2 and TLR 4 mRNA, which are associated with the innate
immune system, suggesting the absence of a quantitative associ-
ation between these systems. 
Abnormalities in TLRs caused by SNPs may change the sus-
ceptibility to infection and inflammatory diseases. For example,
many individuals with a lowered response to inhaled LPS have
TLR 4 polymorphisms, and THP 1 cells transfected with mutated
TLR 4 have a lower response to LPS; in both systems, the abili-
ty to recognize ligands was decreased (13). Among the SNPs of
TLR 4 are Asp299Gly and Thr399Ile, and both of these have been
associated with the increased susceptibility to infection by gram
negative bacteria (14), and the former was reported to be a risk
factor for the development of haematogenous osteomyelitis (27).
Among the TLR SNPs are Arg677Trp and Arg753Gln, and both
of these have been reported to be associated with a lowered abil-
ity to recognize bacterial cell wall components (28). Yet when we
attempted to assess the association of each of these TLR SNPs
with OME, we did not observe any correlation. The frequency
of each of these polymorphisms has been reported to be low. For
example, in patients with periodontitis, the frequency of TLR 4
(Asp299Gly) and TLR 2 (Arg753Gln) has been reported to be
2.9% and 4.1%, respectively (15), and in osteomyelitis patients,
the frequency of TLR 4 (Asp299Gly) and TLR 2 (Arg753Gln)
has been reported to be 3.8% and 0%, respectively (27). Since
we only assessed 60 patients, it was possible that none of these
SNPs was present.
Although TLRs are highly expressed on monocytes, they are
also expressed on other human tissues. Therefore, TLR polymor-
phisms may not be expressed in middle ear fluid (18). In addition,
we did not assess TLRs on the immunocytes in the middle ear
cavity, but on the retained fluid. Thus, the effects of immunocytes
could not be ruled out. 
CONCLUSION
We have shown here that TLR 2 and TLR 4, which are both res-
ponsible for innate immunity, are expressed in the fluid in the
middle ear cavity. This suggests that TLRs play an important role
in the immunological process during OME. However, the TLR
SNPs involved in the susceptibility to infection were not detect-
ed in this study’s samples. 
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